Podcasts

TWiV Episode 300Watch Latest Video Subscribe to Video Feed

ICAAC-Live-Banner

twiv_banner

twim_mwsite_badge

bacteriofilesbanner

isbadge

yellowstonelogo

Subscribe Learn More

mts_banner

This Week in Parasitism

a-radio

MicrobeWorld App

appsquarebannerad200x200

Join MicrobeWorld

Subscribe via Email

subscribe

Microbes After Hours

MW-Site-Banner-200x200

Click for more "Microbes After Hours" videos

Featured Image

Featured Video

Crowdsourced Microbes Heading to Station

Supporters

ASM House 200X200

Getting Started with MicrobeWorld

More "How to" Videos:
| |
|

ICAAC 2013 - This Week in Microbiology with Vincent Racaniello


Hosts:  Read More

ICAAC 2013 - The Role of Vitamin D Supplements in Preventing and Treating Disease

 


There is much interest in the role of nutrients and micronutrients in the support of host defense against infections. How... Read More

New technology transforms research in viral biology

Researchers at The Mount Sinai Medical Center have developed an innovative system to test how a virus interacts with cells in the body—to see, for example, what happens in lung cells when a deadly respiratory virus attacks them.

In the journal Cell Host & Microbe, investigators say such a tec... Read More

Biologists uncover mechanisms for cholera toxin's deadly effects

Biologists at the University of California, San Diego have identified an underlying biochemical mechanism that helps make cholera toxin so deadly, often resulting in life-threating diarrhea that causes people to lose as much as half of their body fluids in a single day.

Two groups of scientis... Read More

ICAAC 2013 - The Role of the Microbiome in Infection Control


The disruption of the human microbiome through use of antimicrobials is a topic of growing interest among healthcare epidemiologist... Read More

ICAAC 2013 - Shingles Vaccine Coverage Low in Elderly Americans


Almost 1 out of every 3 people in the United States will develop shingles during their lifetime. Despite the approval and recommend... Read More

ICAAC 2013 - Human Interferon Kills Resistant H7N9 Influenza


During the April 2013 avian influenza A (H7N9) outbreak, more than 130 human infections with H7N9 were reported. Most patients had ... Read More

Shingles Vaccine Coverage Low in Elderly Americans - ICAAC 2013

Almost 1 out of every 3 people in the United States will develop shingles during their lifetime. Despite the approval and recommendation by the FDA of a shingles vaccine for adults over 50, only 16% of American seniors over 60 are vaccinated. Vaccinations are even lower for those aged 50-60. A... Read More

Human Interferon Kills Resistant H7N9 Influenza - ICAAC 2013

During the April 2013 avian influenza A (H7N9) outbreak, more than 130 human infections with H7N9 were reported. Most patients had severe respiratory illness and 44 people have died. Studies suggest that the H7N9 virus has developed resistance to oseltamivir. A human interferon already in use fo... Read More

ICAAC to Feature Higher Cure Rate Options for Hepatitis C

New therapeutic regimens are in the works to permanently curb many hepatitis C infections. Delegates attending the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) will be privy to the latest, cutting-edge information.

"There will be a symposium on what every infe... Read More

2013 ICAAC Overview Briefing

Members of the ICAAC Program Committee present highlights by day of the ICAAC meeting and discuss sessions of particular interest. Host: Michael Schmidt, Medical University of South Carolina, Charleston, SC Participants: Craig E. Rubens, Seattle Children's Hospital Research Institute, Seattle... Read More

ICAAC 2013 C.difficile Update with Kelly Daniels and Philip Chung

Patients getting medical care can catch serious infections called healthcare-associated infections (HAIs). While most types of HAIs are declining, one -- caused by the bacterium Clostridium difficile --continues to grow. C. difficile causes diarrhea linked to 14,000 American deaths each year. Pa... Read More

Scientists Engineer Strain of MERS Coronavirus for Use in a Vaccine

Scientists have developed a strain of the Middle East respiratory syndrome coronavirus (MERS-CoV) that could be used as a vaccine against the disease, according to a study to be published in mBio®, the online open-access journal of the American Society for Microbiology. The mutant MERS virus, rM... Read More

ICAAC 2013 - C. difficile Update


Patients getting medical care can catch serious infections called healthcare-associated infections (HAIs). While most types of HAIs... Read More

ICAAC 2013 - ICAAC Highlights


Members of the ICAAC Program Committee present highlights by day of the ICAAC meeting and discuss sessions of particular interest.<... Read More

TWiP 59: Apicomplexity



Hosts: Vincent Racaniello and Dickson Despommier


Vincent and Dickson update... Read More

TWiP 59 letters

Allan writes:


You have the best podcast on the web, hands down. I use your TWiP episodes in both my undergraduate and graduate classes.
Thanks.


I've recently seen a family in Hawaii with recurrent pathogenic Blastocystis hominis and Dientamoeba fragilis a... Read More

Bad research rising: The 7th Olympiad of research on biomedical publication

What do the editors of medical journals talk about when they get together? So far today, it’s been a fascinating but rather grim mixture of research that can’t be replicated, dodgy authorship, plagiarism and duplicate papers, and the general rottenness of citations as a measure of scientific imp... Read More

Disease-causing genes spread easily in emerging lethal fungus infection

A rare, emerging fungal disease that is spreading throughout Canada and Northwestern USA can easily pass its deadly genes to related fungal strains within the species but less readily to more distant relatives, according to a study part-funded by the Wellcome Trust.

The findings will help to ... Read More

Drug Cocktail That Protects Monkeys From Deadly Virus May Aid Humans

A combination of two well-known antiviral drugs protects monkeys against MERS and could potentially be used to save humans from the lethal disease, scientists said on Sunday.

Researchers at the National Institute of Allergy and Infectious Diseases gave the drugs, ribavirin and interferon, to ... Read More

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use